Concepedia

Andrew Q. Viet

AQ

Statistics

Publications

9

Citations

420

H-Index

9

Active since

1993

Affiliations

GlaxoSmithKline (United States)(Current)

Research Triangle Park Foundation

Bristol-Myers Squibb (United States)

Andrew Q. Viet is an author at GlaxoSmithKline (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

1993–2020

9

Publications

9

Development of Dihydropyridone Indazole Amides as Selective Rho-Kinase Inhibitors

Krista Goodman, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 156 citations · Full text

, , +17

Potent, Selective and Orally Bioavailable Dihydropyrimidine Inhibitors of Rho Kinase (ROCK1) as Potential Therapeutic Agents for Cardiovascular Diseases

Clark A. Sehon, Gren Z. Wang, Andrew Q. Viet et al. · Journal of Medicinal Chemistry · 2008 · 72 citations · Full text

, , +13

Discovery of Aminofurazan-azabenzimidazoles as Inhibitors of Rho-Kinase with High Kinase Selectivity and Antihypertensive Activity

Robert A. Stavenger, Haifeng Cui, Sarah E. Dowdell et al. · Journal of Medicinal Chemistry · 2006 · 71 citations · Full text

, , +17

Triazolopyrimidines identified as reversible myeloperoxidase inhibitors

Franck Duclos, Lynn M. Abell, David Harden et al. · MedChemComm · 2017 · 29 citations

, , +16

Potent Triazolopyridine Myeloperoxidase Inhibitors

Nicholas R. Wurtz, Andrew Q. Viet, Scott A. Shaw et al. · ACS Medicinal Chemistry Letters · 2018 · 28 citations · Full text

, , +16

1–5 of 9